Quick-hit anxiety med may calm light-triggered seizures
NCT ID NCT02351115
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This small study tested whether a single dose of Staccato Alprazolam (a fast-acting form of a common anxiety drug) could reduce seizure-related brain activity in people with photosensitive epilepsy. Five adults with a history of light-triggered brain responses took the drug or a placebo. The main goal was to see if the drug narrowed the range of flashing lights that cause abnormal brain activity. Results may help guide future treatments for epilepsy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPILEPSY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Consultants in Epilepsy & Neurology, PLLC
Boise, Idaho, United States
-
New York University Epilepsy Center
New York, New York, United States
-
University of Pennsylvania - Penn Epilepsy Center
Philadelphia, Pennsylvania, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can MRI reveal the Brain's response to deep brain stimulation?
- Can community hospitals in zambia master severe disease care?
- Can mindfulness rewire the mind to lift depression in epilepsy?
- A break from seizure pills: could less medication mean better living?
- Can invisible electric fields quiet the Brain's seizure signals?
- Can a new drug tame severe childhood epilepsy?